Skip to content

MAP PHARMACEUTICALS, INC.

CIK 0001401923

← back to feed
Revenue (TTM)
$23.62M
−57.4% YoY Q3 Oct 2012
Net Income (TTM)
−$35.57M
+39.8% YoY Q3 Oct 2012
EPS Diluted (TTM)
−$0.93
Q3 Oct 2012
Gross Margin
—
Q3 Oct 2012
Operating Margin
-150.4%
Q3 Oct 2012
Net Margin
-150.6%
Q3 Oct 2012
Free Cash Flow (TTM)
$27.96M
Q3 Oct 2012
Cash
$114.22M
Q3 Oct 2012
Total Debt
$1.69M
Q3 Oct 2012
Shares Outstanding
35.29M sh
Q3 Oct 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings